.svg){kind=small}
Apr-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the competitive cannabis market of Ohio, Farmaceutical Rx (Frx) has demonstrated a varied performance across different product categories. Notably, in the Concentrates category, the brand maintained a presence within the top 30 brands at the beginning of the year, ranking 22nd in January 2024, but did not rank in February and March, before reappearing at the 23rd position in April 2024. This fluctuation highlights a challenge in maintaining a consistent market position, though the re-entry in April suggests a potential rebound. In contrast, the brand's performance in the Edibles category shows a significant gap, with a ranking of 43rd in January 2024 and no subsequent rankings, indicating a struggle to capture a significant share of the market in this category.
Furthermore, Farmaceutical Rx (Frx) has shown notable results in the Flower and Vapor Pens categories within the Ohio market. The brand's rankings in the Flower category have seen slight variations, moving from 26th in January 2024 to 24th in February, dropping to 30th in March, and not ranking in April, which may suggest a competitive but challenging environment. Despite these fluctuations, the sales in January 2024 for the Flower category were significant, indicating a strong consumer demand for their products. The Vapor Pens category tells a story of persistence, with the brand consistently ranking in the low forties from January to April 2024, which, while showing room for growth, underscores a steady presence in a highly competitive segment. These insights into Farmaceutical Rx (Frx)'s performance across different categories and over time reveal a brand navigating the complexities of the Ohio cannabis market with varying degrees of success.
Competitive Landscape
In the competitive landscape of the Vapor Pens category in Ohio, Farmaceutical Rx (Frx) has shown a consistent position outside the top 20 brands, with rankings fluctuating slightly from 43rd in January to 42nd in April 2024. This indicates a struggle to capture a significant market share in comparison to its competitors. Notably, Standard Farms and Woodward Fine Cannabis have demonstrated stronger performance, ranking within the top 30 during the same period, with Standard Farms even showing a slight improvement in rank from 29th to 37th. This suggests that while Farmaceutical Rx (Frx) is facing challenges in climbing the ranks, competitors like Standard Farms and Woodward Fine Cannabis are managing to maintain a more favorable position in the market. Other brands such as Lighthouse Sciences and Aura (OH) also fluctuated in rankings but remained closer to Farmaceutical Rx (Frx), indicating a tightly contested segment of the market. The sales trends reflect these rankings, with Farmaceutical Rx (Frx) experiencing a decrease in sales from January to April 2024, further emphasizing the brand's need to strategize against its competitors to improve its market position in Ohio's Vapor Pens category.
Notable Products
In April 2024, Farmaceutical Rx (Frx) saw Banana Sherbert Live Resin Sugar (0.84g) from the Concentrates category as its top-selling product, with remarkable sales figures reaching 522 units. Following closely were the Cali-O Distillate Cartridge (0.5g) from the Vapor Pens category, securing the second position with a notable improvement from its fourth rank in the previous month. Tied for the third rank were three products from the Vapor Pens category: Citrus Smoothie Distillate Cartridge (0.5g), Creamsicle Distillate Cartridge (0.5g), and Granddaddy Purple Distillate Cartridge (1g), each showcasing consistent popularity without any sales figures mentioned. This ranking represents a significant shift in consumer preferences, with Concentrates taking the lead over Vapor Pens, which dominated the rankings in prior months. The data indicates a dynamic market, with Farmaceutical Rx (Frx) products experiencing shifts in consumer demand and product popularity over time.
Top Selling Cannabis Brands
